Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease
Clinical trial NCT01018875 · COMPLETED
Trial details
- NCT number
- NCT01018875
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-02-01
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.